Roche to Acquire 100% Of Privately-held mtm Laboratories

Ventana Medical Systems, a member of the Roche, said Roche has signed an agreement under which it will acquire 100% of mtm laboratories, a privately-held company based in Heidelberg, Germany.

As per the terms of the agreement, Roche will pay mtm shareholders an upfront payment of around €130 million, or $180 million, as well as up to approximately €60 million, or $85 million, upon reaching performance-related milestones.

The transaction is subject to customary closing conditions and is expected to close in the coming weeks.

 

Company

F. Hoffmann-La Roche Ltd


4070 Basel
Switzerland

Company contact







Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.